Teva Canada launches Celebrex generic
TORONTO — Teva Canada Ltd. has released a generic version of Pfizer Inc.’s arthritis pain drug Celebrex (celecoxib). Teva said…
November 18, 2014 by Chain Drug Review Supplier News
TORONTO — Teva Canada Ltd. has released a generic version of Pfizer Inc.’s arthritis pain drug Celebrex (celecoxib). Teva said…
November 18, 2014 by Chain Drug Review Supplier News
NEW YORK — Cosmetics and beauty care giant Revlon Inc. has relaunched its brand with a global tagline, its first…
November 18, 2014 by Chain Drug Review Supplier News
WASHINGTON — Patrick Lockwood-Taylor, vice president of personal health care for North America and digestive wellness design at Procter &…
November 17, 2014 by Chain Drug Review Supplier News
FORT WORTH, Texas — Galderma Laboratories has unveiled a new look for its Cetaphil RestoraDerm line of eczema-soothing products. Galderma…
November 17, 2014 by Chain Drug Review Supplier News
DUBLIN — Actavis PLC is acquiring Allergan Inc. in a transaction valued at about $66 billion. The combination will create…
November 14, 2014 by Chain Drug Review Supplier News
PRINCETON, N.J. — The Food and Drug Administration is reclassifying methylphenidate hydrochloride extended-release tablets from Kremers Urban Pharmaceuticals Inc. as…
November 13, 2014 by Chain Drug Review Supplier News
CINCINNATI and OMAHA, Neb. — Conglomerate Berkshire Hathaway Inc. has agreed to acquire the Duracell battery business from Procter &…
November 12, 2014 by Chain Drug Review Supplier News
NORWALK, Conn. — Information and imaging technology giant Xerox is making an investment in telehealth provider HealthSpot Inc. Xerox said…